Primary Record
RIFAPENTINE
- In stock
- 3,028 g
- Purity
- 99.3 %
- CAS
- 61379-65-5
Compound Identifiers & Properties
- CAS
- 61379-65-5
- PubChem CID
- 135403821
- SMILES
- C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C6CCCC6)/C
- Canonical SMILES
- CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C
Names & Synonyms
- RIFAPENTINE
- Priftin
- Rifapentin
- Rifapentina
- Prifitin
- Cyclopentylrifampicin
- Rifapentinum
- rifampin
- Rifamycin AF/ACPP
- Rifapex
- 61379-65-5
- Cyclopentyl rifampin
- Priftin (TN)
- MDL 473
- Rifapentinum [Latin]
- Rifapentina [Spanish]
- KTC-1
- MDL-473
- Rifampicin S-Na Sodium
- Antibiotic DL 473IT
- RefChem:57295
- Rifapentine Hydrochloride
- RIFAPENTINE [MI]
- KTC 1
- MDL473
- RIFAPENTINE [INN]
- XJM390A33U
- Rifapentine (USAN/INN)
- ANTIBIOTIC DL-473IT
- DTXSID8041115
- MFCD00866806
- RIFAPENTINE [USAN]
- CHEBI:45304
- RIFAPENTINE [VANDF]
- CHEMBL1660
- RIFAPENTINE [MART.]
- UNII-XJM390A33U
- DL 473
- DL-473
- SCHEMBL41590
- RIFAPENTINE [WHO-DD]
- DL 473;Cyclopentylrifampicin
- Rifapentine [USAN:INN:BAN]
- WDZCUPBHRAEYDL-GZAUEHORSA-N
- DTXCID6021115
- SCHEMBL29359039
- SCHEMBL29913543
- C47H64N4O12
- DL 473-IT
- GTPL12014
- RIFAPENTINE [ORANGE BOOK]
- DL473
- HMS3713M16
- R-773
- DL-4-73
- DRG-0283
- 3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin
- EINECS 262-743-9
- BBF-03916
- BDBM50248298
- MSK158462
- AKOS024255723
- ACN-048196
- AR27731
- CCG-220467
- DB01201
- KS-1409
- R-77-3
- R773
- SID:53787525
- SY102391
- CID:135403821
- R 77-3
- B2127
- FT-0653692
- C08059
- D00879
- J90035
- [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
- AB01209744-01
- AB01209744-03
- AB01209744_04
- Rifamycin, 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)-
- 3-[N-(4-Cyclopentyl-1-piperazinyl)formimidoyl]rifamycin
- 379R655
- A847176
- C018421
- M000473
- Q3935297
- 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)rifamycin SV
- 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)-rifamyci
- 3-(4-Cyclopentyl-1-piperazinyl)iminomethylrifamycin SV
- 3-(N-(4-Cyclopentyl-1-piperazinyl)formimidoyl)rifamycin
- 3-[[(4-Cyclopentyl-1-piperazinyl)imino]methyl]rifamycin
- 3-((4-CYCLOPENTYL-1-PIPERAZINYL)IMINO)METHYL)RIFAMYCIN
- (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
- RPT
- ((7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-((E)-(4-cyclopentylpiperazin-1-yl)iminomethyl)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl) acetate
- (2R,16S,17R,18R,19R,20S,21S,22S,23S)-8-{[(4-CYCLOPENTYLPIPERAZIN-1-YL)IMINO]METHYL}-5,6,9,17,19-PENTAHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-1,11-DIOXO-1,2-DIHYDRO-2,7-(EPOXYPENTADECA[1,11,13]TRIENOIMINO)NAPHTHO[2,1-B]FURAN-21-YL ACETATE
- (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)-21-(Acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione
- (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate
- (7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,21Z)-26-((1E)-((4-cyclopentylpiperazin-1-yl)imino)methyl)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(28),2,4,9,19,21,23,25(29),26-nonaen-13-yl acetate
- [[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-pentahydroxy-methoxy-heptamethyl-dioxo-[?]yl] acetate
- 127923-87-9
- 262-743-9
- 3-[[(4-Cyclopentyl-1-piperazinyl)imino]methyl]-rifamycin; 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.; Antibiotic DL 473IT; Cyclopentylrifampicin; DL 473; KTC 1; MDL 473; Prifitin; Priftin; R 77-3; Rifamycin AF/ACPP; Rifapentin; Rifapentine
- RPE